Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Japan Depression Screening Mental Health Market

ID: MRFR/HC/54518-HCR
200 Pages
Satyendra Maurya
March 2026

Japan Depression Screening Mental Health Market Research Report By Indication (Major Depressive Disorder, Anxiety Distress, Bipolar Disorder, Psychotic Disorders, Others), By Diagnosis (Psychological Tests, Blood Tests, Pharmacogenomic Testing, Others) and By End User (Hospitals and Clinics, Home-based, Research and Academic Institutes) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Japan Depression Screening Mental Health Market Infographic
Purchase Options

Japan Depression Screening Mental Health Market Summary

As per Market Research Future analysis, the Japan depression screening market size was estimated at 27.39 USD Million in 2024. The Japan depression screening-mental-health market is projected to grow from 28.79 USD Million in 2025 to 47.23 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 5.0% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Japan The depression screening market is experiencing a transformative shift towards technology integration and preventive care.

  • Technology integration in screening processes is reshaping mental health assessments.
  • Government initiatives and policy support are fostering a more robust framework for mental health services.
  • Preventive mental health care is gaining traction, especially among younger demographics.
  • Rising awareness of mental health issues and increased investment in mental health infrastructure are key drivers of market growth.

Market Size & Forecast

2024 Market Size 27.39 (USD Million)
2035 Market Size 47.23 (USD Million)
CAGR (2025 - 2035) 5.08%

Major Players

UnitedHealth Group (US), Anthem (US), Cigna (US), Kaiser Permanente (US), CVS Health (US), Teladoc Health (US), LivaNova (GB), Mindstrong Health (US), Talkspace (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Japan Depression Screening Mental Health Market Trends

The depression screening-mental-health market is currently experiencing notable shifts, driven by an increasing awareness of mental health issues among the population. In Japan, the government has been actively promoting mental health initiatives, which has led to a rise in the demand for screening tools and services. This heightened focus on mental well-being is reflected in various sectors, including healthcare and education, where mental health screenings are becoming more integrated into routine practices. Furthermore, the stigma surrounding mental health appears to be gradually diminishing, encouraging individuals to seek help and participate in screening programs. Moreover, technological advancements are playing a crucial role in shaping the landscape of the depression screening-mental-health market. Digital platforms and mobile applications are emerging as effective tools for screening and monitoring mental health conditions. These innovations not only enhance accessibility but also provide users with personalized resources and support. As a result, the market is likely to witness a surge in the adoption of these technologies, which could further facilitate early detection and intervention for depression and related disorders. Overall, the current trends suggest a promising future for the depression screening-mental-health market, with ongoing efforts to improve mental health awareness and access to screening services.

Integration of Technology in Screening Processes

The incorporation of digital tools and mobile applications is transforming the way depression screening is conducted. These technologies offer convenient access to screening resources, enabling individuals to assess their mental health from the comfort of their homes. This trend is likely to enhance engagement and participation in screening programs.

Government Initiatives and Policy Support

The Japanese government actively promotes mental health awareness through various initiatives. This support is fostering a more favorable environment for the development and implementation of depression screening services, which may lead to increased accessibility and utilization.

Focus on Preventive Mental Health Care

There is a growing emphasis on preventive measures in mental health care, particularly in the context of depression. This trend indicates a shift towards early detection and intervention, with screening becoming a critical component of overall health strategies.

Japan Depression Screening Mental Health Market Drivers

Aging Population and Mental Health Needs

Japan's demographic shift towards an aging population presents a unique challenge and opportunity for the depression screening-mental-health market. With over 28% of the population aged 65 and older, there is a significant need for mental health services tailored to older adults. This demographic is particularly vulnerable to depression, often exacerbated by isolation and health issues. As a result, healthcare providers are increasingly focusing on screening and intervention strategies for this age group. The market is likely to grow as more resources are allocated to address the mental health needs of the elderly.

Rising Awareness of Mental Health Issues

In Japan, there is a growing awareness regarding mental health issues, particularly depression. depression screening services. Public campaigns and educational programs have been instrumental in reducing stigma associated with mental health, encouraging individuals to seek help. According to recent surveys, approximately 30% of the population acknowledges experiencing mental health challenges, which indicates a substantial market potential. As more people recognize the importance of mental health, the depression screening-mental-health market is expected to expand, with increased participation in screening programs and consultations.

Technological Advancements in Screening Tools

Technological advancements are playing a crucial role in the evolution of the depression screening-mental-health market in Japan. The development of digital tools and mobile applications for mental health assessment is gaining traction, allowing for more accessible and efficient screening processes. These innovations can potentially reach a broader audience, particularly younger populations who are more inclined to use technology for health-related issues. As these tools become more sophisticated and user-friendly, they are likely to enhance the overall effectiveness of screening efforts, thereby contributing to the growth of the market.

Integration of Mental Health into Primary Care

Integrating mental health services into primary care settings is increasingly prevalent in Japan. This approach facilitates early detection and intervention for depression, thereby enhancing the effectiveness of the depression screening-mental-health market. By training primary care providers to recognize and address mental health issues, the likelihood of individuals receiving timely screenings increases. Studies suggest that integrated care models can improve patient outcomes and reduce healthcare costs, making this a promising direction for the market. As more healthcare systems adopt this model, the demand for screening services is expected to rise.

Increased Investment in Mental Health Infrastructure

The Japanese government has recognized the necessity of improving mental health infrastructure, which is expected to bolster the depression screening-mental-health market. Recent budget allocations indicate a commitment to enhancing mental health services, with an increase of approximately 15% in funding for mental health programs. This investment aims to expand access to screening and treatment options, particularly in underserved areas. As facilities improve and more professionals enter the field, the market is poised for growth, providing better resources for individuals seeking mental health support.

Market Segment Insights

By Screening Method: Self-Assessment (Largest) vs. Digital Screening Tools (Fastest-Growing)

In the Japan Depression Screening Mental Health Market, the screening methods are diversely distributed, with Self-Assessment methods commanding the largest share. These methods are favored for their accessibility and simplicity, allowing individuals to evaluate their mental health efficiently without the need for immediate professional intervention. Following closely are Digital Screening Tools, which are rapidly gaining popularity due to their integration with technology and growing acceptance among the younger population who prefer digital solutions for health management. Growth trends indicate a significant shift toward more innovative and accessible screening methods. The COVID-19 pandemic has accelerated the adoption of Digital Screening Tools and Telehealth Assessments, driven by the convenience they offer. Furthermore, increased awareness of mental health issues and destigmatization efforts in Japan contribute to higher usage rates of these screening methods, creating a promising outlook in the sector.

Self-Assessment (Dominant) vs. Telehealth Assessments (Emerging)

Self-Assessment remains the dominant method in the Japan depression screening mental health market, appealing to individuals due to its ease of use and privacy. This traditional approach allows users to engage with their mental health at their own pace, fostering a sense of control and empowerment. On the other hand, Telehealth Assessments are emerging as a significant alternative, especially post-pandemic, as they bridge the gap between patients and professionals in remote settings. This method enhances access to mental health services, particularly for those in under-served areas. Both methods serve distinct demographics, with Self-Assessment appealing to those preferring autonomy and Telehealth Assessments catering to individuals seeking professional guidance and increased support.

By Demographic Factors: Age (Largest) vs. Gender (Fastest-Growing)

In the Japan Depression Screening Mental Health Market, age demographics showcase a significant market share distribution, with older adults representing the largest segment. This trend is driven by a rising awareness and recognition of mental health issues among older populations, leading to increased screening. Conversely, the gender demographic reflects a growing emphasis on addressing mental health in men, making the gender segment the fastest-growing area, as more initiatives are launched to destigmatize mental health care for males.

Age: 60+ (Dominant) vs. Gender: Male (Emerging)

The age demographic of 60+ signifies a dominant presence in the Japan depression screening mental health market due to a higher prevalence of depression in older adults and greater healthcare accessibility for this population. Meanwhile, the male gender segment is emerging rapidly, driven by targeted campaigns and awareness programs aimed at encouraging male participation in screening. Men have traditionally been less likely to seek help, but emerging societal shifts are gradually altering these patterns, resulting in an increased focus on male mental health screenings. This evolution is critical, as it signals a proactive approach to mental health across different age groups and genders.

By Severity of Depression: Moderate Depression (Largest) vs. Severe Depression (Fastest-Growing)

In the Japan Depression Screening Mental Health Market, the distribution of market share among different severity levels of depression is significantly varied. Moderate Depression holds the largest share, driven by its prevalent identification among at-risk populations through screening initiatives. This segment is followed closely by Mild Depression, which still commands a substantial portion of the market. Chronic and Severe Depression, while occupying smaller distributions, are increasingly recognized as critical areas for intervention, leading to a stronger emphasis on specialized screening for these conditions.

Moderate Depression (Dominant) vs. Severe Depression (Emerging)

Moderate Depression is characterized by a marked disruption in daily functioning, often requiring intervention tailored to individual needs. It remains a dominant segment due to widespread awareness and healthcare initiatives aimed at identifying and managing this condition early. In contrast, Severe Depression is an emerging segment, swiftly gaining attention as it demands urgent care and intervention. As mental health initiatives expand and evolve, this segment is marked by an increase in screening rates and greater advocacy for support resources, reinforcing its importance in the overall mental health strategy in Japan. Both segments show the necessity for comprehensive mental health resources and targeted outreach.

By Treatment Pathways: Combined Therapy (Largest) vs. Psychotherapy (Fastest-Growing)

In the Japan Depression Screening Mental Health Market, Treatment Pathways reveal significant dynamics among its four principal segments: Psychotherapy, Pharmacotherapy, Combined Therapy, and Lifestyle Interventions. Currently, Combined Therapy stands out as the largest segment, reflecting a strong preference for an integrated approach that utilizes both medication and therapeutic sessions. Contrastingly, Psychotherapy is establishing itself rapidly as the fastest-growing segment, indicating a shifting focus towards non-pharmacological treatments across the population.

Combined Therapy: Dominant vs. Psychotherapy: Emerging

Combined Therapy, characterized by its dual approach of medication and psychotherapy, is dominating the Japan depression screening mental health market due to its holistic view on treatment effectiveness. This pathway not only appeals to a broad demographic but also aligns well with evolving patient expectations for comprehensive care. On the other hand, Psychotherapy is emerging as a vital component in the treatment landscape. With a growing awareness of mental health, there is an increasing inclination towards therapeutic methods that focus on cognitive, emotional, and behavioral strategies. This growing acceptance is driven by advancements in training and techniques in psychotherapy, leading to enhanced delivery and efficacy in treating depression.

By Awareness and Attitude: Mental Health Literacy (Largest) vs. Stigma Awareness (Fastest-Growing)

In the Japan Depression Screening Mental Health Market, mental health literacy stands out with the largest share, indicating a growing awareness and understanding of mental health issues among the population. This factor has become integral to fostering proactive behaviors towards depression screening, signaling a positive shift in the public's attitude. Conversely, stigma awareness is emerging as the fastest-growing segment, revealing an increasing recognition of the detrimental effects of stigma on seeking mental health care. Overall, these dynamics are reshaping public perceptions and encouraging more open discussions around mental health.

Mental Health Literacy (Dominant) vs. Stigma Awareness (Emerging)

Mental health literacy plays a dominant role in the Japan depression screening market, as it reflects the level of knowledge that individuals possess about mental health conditions, symptoms, and appropriate treatment options. This understanding leads to reduced stigma, encourages help-seeking behaviors, and promotes early intervention. On the other hand, stigma awareness is increasingly recognized as an emerging value, highlighting the societal barriers that discourage individuals from seeking help. As public discourse around depression improves, stigma awareness is becoming essential in therapeutic interventions. As both segments develop, they create a comprehensive framework for addressing mental health issues in Japan.

Get more detailed insights about Japan Depression Screening Mental Health Market

Key Players and Competitive Insights

The depression screening-mental-health market in Japan is characterized by a dynamic competitive landscape, driven by increasing awareness of mental health issues and the growing demand for accessible screening solutions. Key players such as UnitedHealth Group (US), Cigna (US), and Teladoc Health (US) are strategically positioning themselves through digital transformation and innovative service offerings. UnitedHealth Group (US) focuses on integrating technology into its mental health services, enhancing patient engagement and accessibility. Meanwhile, Cigna (US) emphasizes partnerships with local healthcare providers to expand its reach and improve service delivery. Teladoc Health (US) leverages telehealth solutions to provide remote mental health screenings, catering to a population increasingly seeking convenience in healthcare access. Collectively, these strategies contribute to a competitive environment that prioritizes innovation and patient-centric solutions.The market structure appears moderately fragmented, with several players vying for market share. Key business tactics include localizing services to meet regional needs and optimizing supply chains to enhance service delivery. The influence of major players is significant, as they set benchmarks for quality and accessibility, thereby shaping consumer expectations and competitive dynamics.

In October UnitedHealth Group (US) announced a partnership with a leading Japanese telehealth provider to enhance its mental health screening capabilities. This strategic move is likely to bolster its market presence in Japan, allowing for a more tailored approach to local mental health needs. By integrating local expertise with its technological resources, UnitedHealth Group (US) aims to improve patient outcomes and streamline service delivery.

In September Cigna (US) launched a new mental health initiative focused on workplace wellness, targeting corporate clients in Japan. This initiative underscores Cigna's commitment to addressing mental health in the workplace, which is increasingly recognized as a critical component of employee well-being. By aligning its services with corporate wellness programs, Cigna (US) positions itself as a leader in the corporate mental health space, potentially increasing its client base and enhancing service utilization.

In August Teladoc Health (US) expanded its mental health services by introducing AI-driven screening tools designed to provide personalized assessments. This innovation reflects a broader trend towards integrating artificial intelligence in healthcare, aiming to enhance the accuracy and efficiency of mental health screenings. By adopting such technologies, Teladoc Health (US) not only improves its service offerings but also sets a precedent for future developments in the mental health sector.

As of November current trends in the depression screening-mental-health market include a pronounced shift towards digitalization and the integration of AI technologies. Strategic alliances among key players are increasingly shaping the competitive landscape, fostering innovation and enhancing service delivery. The focus appears to be shifting from traditional price-based competition to a model that prioritizes technological advancement, service quality, and supply chain reliability. This evolution suggests that companies will need to differentiate themselves through innovative solutions and strategic partnerships to remain competitive in the rapidly changing market.

Key Companies in the Japan Depression Screening Mental Health Market include

Industry Developments

In recent months, the Japan Depression Screening Mental Health Market has seen significant activity, shaped by ongoing efforts to enhance mental health initiatives in the country. Recent developments include advancements in digital mental health solutions by companies like Fujitsu and LINE Corporation, focusing on integrating Artificial Intelligence into their screening processes. Notable growth has been observed in the market valuation of companies such as Astellas Pharma and Eisai, reflecting a rising demand for mental health services amid a growing awareness of depression and mental health issues.

Moreover, in July 2023, Takeda Pharmaceutical announced a strategic partnership with iTHRIVE, aiming to broaden access to depression screening tools. 

The past couple of years also witnessed major events, including Mitsubishi Tanabe Pharma’s emphasis on Research and Development in depression treatment available in Japan, further underlining the increasing focus on mental health solutions. The Japanese government is also actively promoting better mental health policies, fostering an environment conducive to growth in this market segment. Overall, the combination of corporate activities and public health initiatives is driving evolution within the Japan Depression Screening Mental Health Market.

Future Outlook

Japan Depression Screening Mental Health Market Future Outlook

The Depression Screening Mental Health Market in Japan is projected to grow at a 5.08% CAGR from 2025 to 2035, driven by increasing awareness and technological advancements.

New opportunities lie in:

  • Integration of AI-driven diagnostic tools in clinical settings.
  • Expansion of telehealth services for remote patient monitoring.
  • Development of personalized treatment plans using genetic profiling.

By 2035, the market is expected to achieve substantial growth and innovation.

Market Segmentation

Japan Depression Screening Mental Health Market End User Outlook

  • Hospitals and Clinics
  • Home-based
  • Research and Academic Institutes

Japan Depression Screening Mental Health Market Diagnosis Outlook

  • Psychological Tests
  • Blood Tests
  • Pharmacogenomic Testing
  • Others

Japan Depression Screening Mental Health Market Indication Outlook

  • Major Depressive Disorder
  • Anxiety Distress
  • Bipolar Disorder
  • Psychotic Disorders
  • Others

Report Scope

MARKET SIZE 2024 27.39(USD Million)
MARKET SIZE 2025 28.79(USD Million)
MARKET SIZE 2035 47.23(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.08% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled UnitedHealth Group (US), Anthem (US), Cigna (US), Kaiser Permanente (US), CVS Health (US), Teladoc Health (US), LivaNova (GB), Mindstrong Health (US), Talkspace (US)
Segments Covered Indication, Diagnosis, End User
Key Market Opportunities Integration of digital tools for enhanced depression screening and personalized mental health interventions.
Key Market Dynamics Rising demand for digital mental health solutions drives innovation in depression screening methodologies and technologies.
Countries Covered Japan
Author
Author
Author Profile
Satyendra Maurya LinkedIn
Research Analyst
An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Leave a Comment

FAQs

What is the current market valuation of the Japan depression screening-mental-health market?

<p>The market valuation was $27.39 Million in 2024.</p>

What is the projected market size for the Japan depression screening-mental-health market by 2035?

<p>The market is projected to reach $47.23 Million by 2035.</p>

What is the expected CAGR for the Japan depression screening-mental-health market during the forecast period?

<p>The expected CAGR for the market from 2025 to 2035 is 5.08%.</p>

Which segments are included in the Japan depression screening-mental-health market?

<p>Key segments include Major Depressive Disorder, Anxiety Distress, Bipolar Disorder, Psychotic Disorders, and Others.</p>

What are the valuation ranges for Major Depressive Disorder in the market?

<p>The valuation for Major Depressive Disorder ranges from $10.0 Million to $17.0 Million.</p>

What types of diagnostic tests are utilized in the Japan depression screening-mental-health market?

<p>Diagnostic tests include Psychological Tests, Blood Tests, and Pharmacogenomic Testing.</p>

What is the valuation range for Psychological Tests in the market?

<p>The valuation for Psychological Tests ranges from $10.0 Million to $17.0 Million.</p>

Who are the key players in the Japan depression screening-mental-health market?

<p>Key players include UnitedHealth Group, Anthem, Cigna, Kaiser Permanente, and CVS Health.</p>

What is the expected growth trend for home-based services in the market?

<p>Home-based services are projected to grow, with valuations ranging from $8.21 Million to $13.67 Million.</p>

What is the market valuation for hospitals and clinics in the Japan depression screening-mental-health market?

<p>The valuation for hospitals and clinics ranges from $10.95 Million to $18.56 Million.</p>

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions